Quality of life after curative resection for rectal cancer in patients treated with adjuvant chemotherapy compared with observation: results of the randomized phase III SCRIPT Trial. Dis Colon Rectum 2019; 62: 711-720
Published: 24th January 2020
Authors: van der Valk MJ, Hilling DE, Meershoek-Klein Kranenbarg E, Peeters K, Kapiteijn E, Tsonaka R et al.
Results were available for 226 patients. The addition of chemotherapy resulted in a reduction in quality of life overall (P=0.006), and in physical functioning (P<0.001). All differences between the groups had resolved after twelve months.Pubmed Link
You may also be interested in
Does a longer waiting period after neoadjuvant radio-chemotherapy improve the oncological prognosis of rectal cancer? Three years’ follow-up results of the Greccar-6 randomized multicenter trial. Ann Surg 2019; 270: 747-754
Authors: Lefèvre J, Mineur L, Cachanado M, Denost Q, Rouanet P, de Chaisemartin C et al.
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicenter, open-label, randomized trial. Lancet Gastroenterol Hepatol 2019; 4: 761-770
Authors: Klaver CEL, Wisselink DD , Punt CJA , Snaebjornsson P , Crezee J, Aalbers AG et al.
Quadratus lumborum block versus perioperative intravenous lidocaine for postoperative pain control in patients undergoing laparoscopic colorectal surgery: a prospective, randomized, double-blind controlled clinical trial. Ann Surg 2018; 268: 769-775.
Authors: Dewinter G, Coppens S, Van de Velde M, D’Hoore A, Wolthuis A, Cuypers E et al.
Authors: Grothey A, Sobrero AF, Shields AF, Yoshino T, Paul J, Taieb J et al.
A randomized control trial of preoperative oral antibiotics as adjunct therapy to systemic antibiotics for preventing surgical site infection in clean contaminated, contaminated, and dirty type of colorectal surgeries. Dis Colon Rectum 2017; 60: 1291-1298.
Authors: Anjum N, Ren J, Wang G, Li G, Wu X, Dong H et al.
Effect of coffee on the length of postoperative ileus after elective laparoscopic left-sided colectomy: a randomized, prospective single-center study. Dis Colon Rectum 2015; 58: 1064-1069.
Authors: Dulskas A, Klimovskij M, Vitkauskiene M, Samalavicius N
Capecitabine plus oxaliplatin compared with fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results of the NO16968 randomized controlled phase III trial. J Clin Oncol 2015; 33: 3733-3740.
Authors: Schmoll H-J, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E et al. et al.
Prospective, randomized study on the use of a prosthetic mesh for prevention of parastomal hernia of permanent colostomy. Dis Colon Rectum 2015; 58: 943-949.
Authors: Vierimaa M, Klintrup K, Biancari F, Victorzon M, Carpelan-Holmström M, Kössi J et al. et al.
Efficacy of gum chewing on bowel movement after open colectomy for left-sided colorectal cancer: a randomized clinical trial. Dis Colon Rectum 2015; 58: 1058-1063.
Authors: Kobayashi T, Masaki T, Kogawa K, Matsuoka H, Sugiyama M
Oral mechanical bowel preparation for colorectal surgery: systematic review and meta-analysis. Dis Colon Rectum 2015; 58: 698-707.
Authors: Dahabreh I, Steele D, Shah N, Trikalinos Thomas A
A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with same poxvectors plus GM-CSF for resected metastatic colorectal cancer. Ann Surg 2013; 285: 879–886.
Authors: Morse MA, Niedzwiecki D, Marshall JL, Garrett C, Chang DZ, Aklilu M et al. et al.
Bevacizumab in stage II-III colon cancer: five year update of the National Surgical Adjuvant Breast and Bowel Project C-08 Trial. J Surg Oncol 2013; 31: 359-364.
Authors: Allegra CJ, Yothers G, O’Connell MJ, Sharif S, Petrelli NJ, Lopa SH et al. et al.